Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer (GOG-3106)
- GynOnco Group Team

- Aug 16
- 1 min read
STUDY ID: NCT06952660
STATUS: Opening Soon
CONDITION: Cervical Cancer
SPONSOR: Pfizer
FOR MORE INFORMATION VISIT: https://clinicaltrials.gov/study/NCT06952660





